These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22475314)

  • 1. Theragnostic performance of ex vivo testing of haemostatic intervention and clinical effect of recombinant factor VIIa and fibrinogen concentrate.
    Tang M; Wierup P; Christiansen K; Greisen J; Sørensen B
    Thromb Res; 2012 May; 129(5):e263-5. PubMed ID: 22475314
    [No Abstract]   [Full Text] [Related]  

  • 2. Ticagrelor reversal:
    Calmette L; Martin AC; Le Bonniec B; Zlotnik D; Gouin-Thibault I; Bachelot-Loza C; Gaussem P; Godier A
    J Clin Pathol; 2017 Sep; 70(9):733-739. PubMed ID: 28159767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids.
    Fenger-Eriksen C; Tønnesen E; Ingerslev J; Sørensen B
    Acta Anaesthesiol Scand; 2009 Mar; 53(3):332-8. PubMed ID: 19243319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial contact pathway activation masks the haemostatic potential of rFVIIa and NN1731 in thrombocytopenic whole blood.
    Larsen OH; Ezban M; Persson E; Ingerslev J; Sørensen B
    Br J Haematol; 2010 Jul; 150(1):124-7. PubMed ID: 20331467
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.
    Larsen OH; Stentoft J; Radia D; Ingerslev J; Sørensen B
    Br J Haematol; 2013 Jan; 160(2):228-36. PubMed ID: 23151086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery.
    Sørensen B; Asvaldsdottir HS; Gudmundsdottir BR; Onundarson PT
    Thromb Res; 2009 Dec; 124(6):695-700. PubMed ID: 19733387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
    Sørensen B; Ingerslev J
    Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex-vivo response to blood products and haemostatic agents after paediatric cardiac surgery.
    Hvas AM; Andreasen JB; Christiansen K; Ravn HB
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):587-92. PubMed ID: 23571685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate.
    Lindahl TL; Wallstedt M; Gustafsson KM; Persson E; Hillarp A
    Thromb Res; 2015 Mar; 135(3):544-7. PubMed ID: 25596769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo reversal of the anticoagulant effects of edoxaban - comments on the study by Halim et al.
    Marlu R; Polack B; Pernod G
    Thromb Res; 2015 Mar; 135(3):571. PubMed ID: 25628140
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemostatic effect of activated recombinant factor VIIa in Bernard-Soulier syndrome: studies in an in vitro model.
    Tonda R; Galán AM; Pino M; Lozano M; Ordinas A; Escolar G
    Transfusion; 2004 Dec; 44(12):1790-1. PubMed ID: 15584995
    [No Abstract]   [Full Text] [Related]  

  • 12. Ex vivo reversal of the anticoagulant effects of edoxaban.
    Halim AB; Samama MM; Mendell J
    Thromb Res; 2014 Oct; 134(4):909-13. PubMed ID: 25179520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
    Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
    Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming delayed in-vitro response to rFVIIa: effects of rFVIIa and rFVIIa analogue (vatreptacog alfa) concentration escalation in whole blood assays.
    Brophy DF; Martin EJ; Barrett JC; Nolte ME; Kuhn JG; Hedner U; Ezban M
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):541-6. PubMed ID: 21681082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram.
    Lak M; Scharling B; Blemings A; Sharifian R; Maleki Z; Daraee A; Arjmand AR; Hedner U
    Haemophilia; 2008 Jan; 14(1):103-10. PubMed ID: 18070065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic effects of recombinant factor VIIa combined with hemoglobin-based oxygen carrier-201 for prehospital resuscitation of swine with severe uncontrolled hemorrhage due to liver injury.
    Arnaud F; Hammett M; Philbin N; Scultetus A; McCarron R; Freilich D
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):669-77. PubMed ID: 18832908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
    Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
    Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
    Kjalke M; Oliver JA; Monroe DM; Hoffman M; Ezban M; Hedner U; Roberts HR
    Thromb Haemost; 1997 Oct; 78(4):1202-8. PubMed ID: 9364985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in hemostatic intervention after implementation of thromboelastometry.
    Hvas AM; Boas TW; Jensen M; Lindskov C; Folkersen L; Ravn HB
    J Cardiothorac Vasc Anesth; 2012 Apr; 26(2):227-31. PubMed ID: 21924638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.